Find out about Anvisa's priorities for the next biennium
RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.
What are the challenges in ensuring access to high-cost medicines?
WHAT ARE THE STEPS FOR OBTAINING AUTHORIZATION FOR CLINICAL STUDIES IN BRAZIL?
Important circumstances for the submission of drug registration in Brazil
What are the topics of interest and ANVISA’s availability for meetings?